Preliminary results point interest across the rare disease research community, while highlighting underrepresentation of some countries and stakeholders
ERDERA interviews Dorica Dan, President of the Romanian Prader-Willi Association (RPWA), the Romanian National Alliance for Rare Diseases (RONARD) and the Romanian Rare Cancers Association, and Vice-President of EURORDIS–Rare Diseases Europe.
ERDERA has opened its Clinical Trial Call 2026 to support multinational early-phase clinical trials in rare diseases. The call will fund sponsor-led, GCP-compliant studies designed to generate robust clinical evidence, strengthen regulatory readiness and make rare disease trials more feasible across countries.
